<DOC>
	<DOCNO>NCT01797276</DOCNO>
	<brief_summary>Open Label access DCA continue treatment congenital lactic acidosis .</brief_summary>
	<brief_title>Dichloroacetate Treatment Congenital Lactic Acidosis Phase B : Open Label</brief_title>
	<detailed_description>Subjects participate Phase 3 Randomized Controlled Trial DCA treatment Congenital Lactic Acidosis ( CLA ) eligible continue treatment investigational medication DCA dose 25mg/kg/day . Study participant must travel study site bi-annual evaluation study investigator . Bi-annual evaluation include interim medical history review , physical exam , blood collection DCA trough level , urine pregnancy test ( indicate ) .</detailed_description>
	<mesh_term>Acidosis</mesh_term>
	<mesh_term>Acidosis , Lactic</mesh_term>
	<criteria>Diagnosis congenital lactic acidosis Participation Study : # 1831992 : Dichloroacetate Treatment Congenital Lactic Acidosis Intolerance DCA</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Dichloroacetate ( DCA )</keyword>
	<keyword>Congenital Lactic Acidosis ( CLA )</keyword>
	<keyword>acidosis</keyword>
	<keyword>orphan disease</keyword>
</DOC>